COMP <GO>
MTZ vs TMO // ALTMAN Z-SCORE & DEBT/EQUITY
MasTec Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: MTZ 3
— TMO 9
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: TMO
LAST: $177.82 (-1.76%) • MKT CAP: $14.28B
balance-sheet
3.41
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
balance-sheet
4.50
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MTZ VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MTZ | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.80% | 9.30% | -2.50 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.1x | 30.4x | -14.30 | MTZ | /valuation <GO> |
| Free Cash Flow Yield | -0.68% | 2.40% | -3.08 | TMO | /fcf-yield <GO> |
| Operating Margin | 3.40% | 17.40% | -14.00 | TMO | /operating-margins <GO> |
| Net Profit Margin | 2.80% | 15.10% | -12.30 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 16.20% | 3.90% | +12.30 | MTZ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 3.41 | 4.50 | -1.09 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 35.9 | 62.9 | -27.00 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.87 | 0.94 | -0.07 | TMO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.1x | 36.3x | -6.20 | MTZ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $14.28B | $262.22B | -$247.94B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MTZ REV | TMO REV | MTZ GROSS % | TMO GROSS % | MTZ FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $14.30B | $44.56B | — | — | -$97.7M | $6.29B |
| FY 2024 | $12.30B | $42.88B | — | — | $568.0M | $7.27B |
| FY 2023 | $12.00B | $42.86B | — | — | $147.5M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MTZ // BETA 0.87
TMO // BETA 0.94